위진홍 (가톨릭대학교 의과대학)님 | 한빛사연구자 > 한빛사

가톨릭대학교 의과대학

최종업데이트 2026.08.10.

Cancer nanovaccine plus doxorubicin and immune checkpoint blockade overcomes chemoresistance and delays postsurgical recurrence
- J. Nanobiotechnol., 07 August 2026 | https://doi.org/10.1186/s12951-026-04892-3
- 2026-08
- 의약학
- 한빛사논문
- 위진홍(University of Pennsylvania)
  Interview 1
A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology
- Nature, Published: 27 January 2021 | https://doi.org/10.1038/s41586-021-03185-z
- 2021-01
- 한빛사논문
- 위진홍(University of Pennsylvania)
  Interview
Intellectual disability-associated UNC80 mutations reveal inter-subunit interaction and dendritic function of the NALCN channel complex
- Nat. Commun., Published: 03 July 2020, 11, Article number: 3351 (2020) | https://doi.org/10.1038/s41467-020-17105-8
- 2020-07
- 한빛사논문

연구자 ID

저자논문